株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国の遺伝子検査市場の見通し

China Genetic Testing Market Outlook to 2024

発行 GlobalData 商品コード 346055
出版日 ページ情報 英文 35 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.40円で換算しております。
Back to Top
中国の遺伝子検査市場の見通し China Genetic Testing Market Outlook to 2024
出版日: 2017年11月01日 ページ情報: 英文 35 Pages
概要

当レポートでは、中国の遺伝子検査市場について調査分析し、セグメント別の収益実績・予測、カテゴリー別の企業シェア・流通シェア、主要企業のプロファイルなど、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 中国の遺伝子検査市場

  • 収益実績
  • 収益予測
  • 流通シェア:収益別
  • 企業シェア:収益別

第4章 中国の主要企業の概要:遺伝子検査市場

  • 企業概要
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Abbott Laboratories
    • Siemens Healthcare
    • Hologic, Inc.
    • Transgenomic, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen N.V.

第5章 遺伝子検査市場パイプライン製品

第6章 財務取引情勢

  • パートナーシップ

第7章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDMECC2848DB

GlobalData's new report, China Genetic Testing Market Outlook to 2024, provides key market data on the China Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the China Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Introduction 4

  • 2.1 What Is This Report About? 4
  • 2.2 Genetic Testing Market Segmentation 4
  • 2.3 Definitions of Markets Covered in the Report 5

3 Genetic Testing Market, China 6

  • 3.1 Genetic Testing Market, China, Revenue ($m), 2010-2017 6
  • 3.2 Genetic Testing Market, China, Revenue ($m), 2017-2024 8
  • 3.3 Genetic Testing Market, China, Distribution Share by Revenue ($m), 2017 10
  • 3.4 Genetic Testing Market, China, Company Share by Revenue ($m), 2017 11

4 Overview of Key Companies in China, Genetic Testing Market 13

  • 4.1 F. Hoffmann-La Roche Ltd 13
    • 4.1.1 Company Overview 13
  • 4.2 PerkinElmer Inc 13
    • 4.2.1 Company Overview 13
  • 4.3 Abbott Laboratories 13
    • 4.3.1 Company Overview 13
  • 4.4 Hologic Inc 14
    • 4.4.1 Company Overview 14
  • 4.5 Qiagen NV 14
    • 4.5.1 Company Overview 14

5 Genetic Testing Market Pipeline Products 15

6 Financial Deals Landscape 17

  • 6.1 Partnerships 17
    • 6.1.1 Fujian Cosunter Pharmaceutical Forms Joint Venture with Reproductive Genetic Innovations 17
    • 6.1.2 Lucigen Enters into Distribution Agreement with Illumina 18
    • 6.1.3 Luxcel Biosciences and HD Biosciences Enter into Agreement 19
    • 6.1.4 Anhui Anke Biotechnology Plans Joint Venture with Pu Yi 20
  • 6.2 Venture Financing 21
    • 6.2.1 Basecare Medical Device Raises USD15.3 Million in Series B Financing 21
    • 6.2.2 TopGene Raises USD14.4 Million in Series A round of Financing 22
    • 6.2.3 Grandomics Biosciences Raises USD14 Million in Series A Financing 23
    • 6.2.4 Beijing Hope Group Biotech Raises USD14.5 Million in Series A Financing 24

7 Recent Developments 25

  • 7.1 Corporate Communications 25
    • 7.1.1 Jul 20, 2017: Meridian Announces Wholly Foreign Owned Enterprise Office in Beijing, China 25
  • 7.2 Other Significant Developments 25
    • 7.2.1 Oct 17, 2017: WuXi NextCODE Integrates Oxford Nanopore into the Global Platform for Genomic Data 25
    • 7.2.2 Apr 10, 2017: CloudHealth Genomics Makes China's First Sequencing Data Available Using Illumina's NovaSeq 6000 26
    • 7.2.3 Jan 04, 2017: GrandOmics Biosciences Expands Investment in PacBio's Sequel Systems for Precision Medicine Initiative 26
  • 7.3 Product News 27
    • 7.3.1 Oct 23, 2017: TBG Biotechnology First to Receive China FDA Approval for High Resolution HLA Genotyping for Hematopietic Cell Transplantation 27
    • 7.3.2 Feb 23, 2017: CloudHealth Genomics Presents their Unique Market Strategy and ImmuneSeq Panel for both Cancer and Non-Cancer Immunotherapies 27

8 Appendix 29

  • 8.1 Research Methodology 30
    • 8.1.1 Coverage 30
    • 8.1.2 Secondary Research 30
    • 8.1.3 Primary Research 31
    • 8.1.4 Market Modeling and Forecasting 32
    • 8.1.5 Company Share Analysis 33
    • 8.1.6 Distribution Share Analysis 34
    • 8.1.7 Benchmarking 34
  • 8.2 GlobalData Consulting 34
  • 8.3 Contact Us 35
  • 8.4 Disclaimer 35

List of Tables

1.1 List of Tables

  • Table 1: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 7
  • Table 2: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 9
  • Table 3: Genetic Testing Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 10
  • Table 4: Genetic Testing Market, China, Company Share by Revenue ($m), USD Constant, 2017 12
  • Table 5: Genetic Testing Market Pipeline Products 15
  • Table 6: Fujian Cosunter Pharmaceutical Forms Joint Venture with Reproductive Genetic Innovations 17
  • Table 7: Lucigen Enters into Distribution Agreement with Illumina 18
  • Table 8: Luxcel Biosciences and HD Biosciences Enter into Agreement 19
  • Table 9: Anhui Anke Biotechnology Plans Joint Venture with Pu Yi 20
  • Table 10: Basecare Medical Device Raises USD15.3 Million in Series B Financing 21
  • Table 11: TopGene Raises USD14.4 Million in Series A round of Financing 22
  • Table 12: Grandomics Biosciences Raises USD14 Million in Series A Financing 23
  • Table 13: Beijing Hope Group Biotech Raises USD14.5 Million in Series A Financing 24
  • Table 14: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 32

List of Figures

1.2 List of Figures

  • Figure 1: Genetic Testing Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 6
  • Figure 2: Genetic Testing Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 8
  • Figure 3: Genetic Testing Market, China, Company Share (%) 2017 11
Back to Top